Option Care, BioScrip complete merger

Thursday, August 8, 2019

BANNOCKBURN, Ill., and DENVER – Option Care Enterprises and BioScrip have completed their merger, forming a newly combined company named Option Care Health. The deal has met closing conditions, including approval by BioScrip shareholders and the receipt of all necessary regulatory approvals. “Today marks the beginning of an exciting new chapter as we unite two strong organizations with proud histories as market leaders,” said John Rademacher, CEO of Option Care Health. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS. The company will be headquartered in Bannockburn, Ill., and led by Rademacher as CEO and Mike Shapiro as CFO. Harry Kraemer, former chairman and CEO of Baxter International, will serve as chairman of the board. Option Care and BioScrip announced their merger in March.